Brain metastasis is an important cause of death in patients with advanced cancer, and its development begins in a functional microenvironment regulated by cerebrovascular endothelium (CVE) cells and astrocytes of the blood-brain barrier (BBB). However, the molecular pathogenesis of brain metastasis is largely unknown, and there are no molecular biomarkers alerting us on the risk of suffering brain metastasis and that might represent good targets for therapy. The aim of the project was to study the neurovascular microenvironment and the growth pattern of experimental and clinical brain metastasis and the transcriptional activity of the CVE cells in response to soluble factors from cultured astrocytes activated by MDA-231 breast cancer (BC) c...